Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, TDS, WOM

Stuttgart Auction House EPPLI Carries Out One of the Largest Handbag Auctions in Europe


STUTTGART, Germany, Feb. 27, 2020 /CNW/ -- According to a study by the Boston Consulting Group, the market for luxury fashion items is growing by about 6% per year. Record prices are regularly achieved at auctions and in second-hand shops.

On 14th of March, EPPLI will be hosting a best-of auction at Stuttgart's Königsbau where a particularly rare SEKRÈ handbag will be up for bids. Each bag is 100% handmade in 142 steps and made of pure cowhide leather. The hardware (Logoplate) is made of solid, hand polished sterling silver. Dimensions: approx 36 cm (W) x 25 cm (H) x 12 cm (D) / Editorial use of this picture is free of charge. Please quote the source: "obs/auction house EPPLI" (PRNewsfoto/auction house EPPLI)

According to the German industry newspaper Textilwirtschaft (2018), one woman in five already owns a luxury handbag.

EPPLI, founded in 1978, was one of the first to specialising for the upmarket segment of fashion and accessories.

In 2018, the company made international headlines by auctioning one of the world's largest collection of the most desired Hermès luxury bags.

Hermès achieved hammer prices of up to ?36,000 for an extremely limited it-bag "KELLY BAG 35 TEDDY," coll. 2001.

Since then the family business has systematically expanded this division.

Today, the company already employs 80 people, of which 12 of them specifically for the luxury sector search the international markets for selected items.

For the upcoming years, EPPLI aims to catch up with the New York auction house Christie's in this rapidly growing segment. Christie's is currently considered the market leader for luxury handbags in the international auction market.

On 14th of March, EPPLI will be hosting a best-of auction at Stuttgart's Königsbau. Besides sought- after Kelly and Birkin bags by Hermès, a particularly rare SEKRÈ handbag and will be up for bids. From all over the world bidders will be able to participate by telephone or online at www.eppli.com. Strong international bidders are expected again, for this special event.

- Pictures are available at AP Images (http://www.apimages.com) -

Photo - https://mma.prnewswire.com/media/1095716/Eppli_Auction_SEKRE_Handbag.jpg
Photo - https://mma.prnewswire.com/media/1095717/Eppli_Auction_Handbags_Charles_Lindbergh.jpg

Press contact:
Bianca Pop
EPPLI & EPPLI MEDIA
Marktplatz 6
70173 STUTTGART
Tel.: +49-711-997-008-141
Mobile: +49-151-52892578
b.pop@eppli.com

Under the supervision of a notary, the valuable artifacts are cut up and then incorporated into the luxury handbags. Here is an original part of a hand-written letter from CHARLES LINDBERGH (1902-1974) to a friend. Editorial use of this picture is free of charge. Please quote the source: "obs/auction house EPPLI" (PRNewsfoto/auction house EPPLI)

SOURCE auction house EPPLI


These press releases may also interest you

at 07:10
The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for FARXIGA (dapagliflozin) in patients with chronic kidney disease (CKD) will be stopped early following a recommendation from an independent...

at 07:10
IMV Inc. , a clinical-stage biopharmaceutical company (the "Company" or "IMV"), today provided updates on the development of DPX-COVID-19, a vaccine candidate against the novel coronavirus, and on the Company's business and clinical operations amid...

at 07:05
LifeMax Laboratories, Inc. ("LifeMax"), a private company focused on treating orphan diseases that have few or no therapeutic options, today announced the formation of AmMax Bio, Inc. ("AmMax") and an exclusive worldwide license from Amgen for the...

at 07:05
AstraZeneca today announced that IMFINZI® (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide...

at 07:05
ElevateBio, LLC, a Cambridge-based creator and operator of a portfolio of innovative cell and gene therapy companies, today announced it has closed a $170-million Series B financing that will support and accelerate the company's next phase of growth....

at 07:05
Generation Bio and Vir Biotechnology today announced a collaborative research agreement to explore the potential for Generation Bio's non-viral gene therapy platform to extend the impact and reach of Vir's current or future human monoclonal...



News published on 27 february 2020 at 09:30 and distributed by: